Membrane microdomain-associated uroplakin IIIa contributes to Src-dependent mechanisms of anti-apoptotic proliferation in human bladder carcinoma cells

Biology Open

Volumn 1, Issue 10, 2012, Pages 1024-1034

  Kihira, Shigeru ^a   Yoshida, Junpei ^a   Kawada, Yukari ^a   Hitomi, Yuriko ^a   Asada, Tomohisa ^a   Hisatomi, Rie ^a   Ohta, Akina ^a   Iwasaki, Tetsushi ^b   Mahbub Hasan, A K M ^a,c   Fukami, Yasuo ^b   Sato, Ken Ichi ^a  

^a KYOTO SANGYO UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

Anti apoptosis; Bladder cancer; Membrane microdomains; Src; Uroplakin III

Indexed keywords

EID: 84964806410     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20121115     Document Type: Article

References (51)

1. Aleshin, A. and Finn, R. S. (2010). SRC: a century of science brought to the clinic. Neoplasia 12, 599-607.
2. Anderson, R. G. (1998). The caveolae membrane system. Annu. Rev. Biochem. 67, 199-225.
3. Brown, D. A. and London, E. (1998). Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14, 111-136.
4. Chen, C. L., Chan, P. C., Wang, S. H., Pan, Y. R. and Chen, H. C. (2010). Elevated expression of protein kinase Cδ induces cell scattering upon serum deprivation. J. Cell Sci. 123, 2901-2913.
5. Fang, H. Y., Chang, C. L., Hsu, S. H., Huang, C. Y., Chiang, S. F., Chiou, S. H., Huang, C. H., Hsiao, Y. T., Lin, T. Y., Chiang, I. P. et al. (2010). ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cells. J. Cell Sci. 123, 1171-1180.
6. Griffin, J. L. and Shockcor, J. P. (2004). Metabolic profiles of cancer cells. Nat. Rev. Cancer 4, 551-561.
7. Hanahan, D. and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
8. Harris, A. L. (2002). Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38-47.
9. Hemler, M. E. (2005). Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 6, 801-811.
10. Hemmings, B. A. (1997). Akt signaling: linking membrane events to life and death decisions. Science 275, 628-630.
11. Higashiyama, S., Iwabuki, H., Morimoto, C., Hieda, M., Inoue, H. and Matsushita, N. (2008). Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci. 99, 214-220.
12. Hu, P., Deng, F. M., Liang, F. X., Hu, C. M., Auerbach, A. B., Shapiro, E., Wu, X. R., Kachar, B. and Sun, T. T. (2000). Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J. Cell Biol. 151, 961-972.
13. Huang, B. X., Akbar, M., Kevala, K. and Kim, H. Y. (2011). Phosphatidylserine is a critical modulator for Akt activation. J. Cell Biol. 192, 979-992.
14. Hunter, T. (2009). Tyrosine phosphorylation: thirty years and counting. Curr. Opin. Cell Biol. 21, 140-146.
15. Hynes, N. E. and Lane, H. A. (2005). ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5, 341-354.
16. Islam, A., Kageyama, H., Takada, N., Kawamoto, T., Takayasu, H., Isogai, E., Ohira, M., Hashizume, K., Kobayashi, H., Kaneko, Y. et al. (2000). High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19, 617-623.
17. Jenkins, D. and Woolf, A. S. (2007). Uroplakins: new molecular players in the biology of urinary tract malformations. Kidney Int. 71, 195-200.
18. Jenkins, D., Bitner-Glindzicz, M., Malcolm, S., Hu, C. C., Allison, J., Winyard, P. J., Gullett, A. M., Thomas, D. F., Belk, R. A., Feather, S. A. et al. (2005). De novo Uroplakin IIIa heterozygous mutations cause human renal adysplasia leading to severe kidney failure. J. Am. Soc. Nephrol. 16, 2141-2149.
19. Khandelwal, P., Abraham, S. N. and Apodaca, G. (2009). Cell biology and physiology of the uroepithelium. Am. J. Physiol. Renal Physiol. 297, F1477-F1501.
20. Koga, F., Kawakami, S., Fujii, Y., Saito, K., Ohtsuka, Y., Iwai, A., Ando, N., Takizawa, T., Kageyama, Y. and Kihara, K. (2003). Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin. Cancer Res. 9, 5501-5507.
21. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
22. Lai, Y., Ye, J., Chen, J., Zhang, L., Wasi, L., He, Z., Zhou, L., Li, H., Yan, Q., Gui, Y. et al. (2010). UPK3A: a promising novel urinary marker for the detection of bladder cancer. Urology 76, 514.e6-514.e11.
23. Liang, F. X., Riedel, I., Deng, F. M., Zhou, G., Xu, C., Wu, X. R., Kong, X. P., Moll, R. and Sun, T. T. (2001). Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition. Biochem. J. 355, 13-18.
24. Lobban, E. D., Smith, B. A., Hall, G. D., Harnden, P., Roberts, P., Selby, P. J., Trejdosiewicz, L. K. and Southgate, J. (1998). Uroplakin gene expression by normal and neoplastic human urothelium. Am. J. Pathol. 153, 1957-1967.
25. Mahbub Hasan, A. K. M., Sato, K., Sakakibara, K., Ou, Z., Iwasaki, T., Ueda, Y. and Fukami, Y. (2005). Uroplakin III, a novel Src substrate in Xenopus egg rafts, is a target for sperm protease essential for fertilization. Dev. Biol. 286, 483-492.
26. Mahbub Hasan, A. K. M., Ou, Z., Sakakibara, K., Hirahara, S., Iwasaki, T., Sato, K. and Fukami, Y. (2007). Characterization of Xenopus egg membrane microdomains containing uroplakin Ib/III complex: roles of their molecular interactions for subcellular localization and signal transduction. Genes Cells 12, 251-267.
27. Mahbub Hasan, A. K. M., Fukami, Y. and Sato, K. (2011). Gamete membrane microdomains and their associated molecules in fertilization signaling. Mol. Reprod. Dev. 78, 814-830.
28. Matsumoto, K., Satoh, T., Irie, A., Ishii, J., Kuwao, S., Iwamura, M. and Baba, S. (2008). Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer. Urology 72, 444-449.
29. Miyamoto, S., Yagi, H., Yotsumoto, F., Kawarabayashi, T. and Mekada, E. (2006). Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci. 97, 341-347.
30. Moll, R., Wu, X. R., Lin, J. H. and Sun, T. T. (1995). Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am. J. Pathol. 147, 1383-1397.
31. Ohtsuka, Y., Kawakami, S., Fujii, Y., Koga, F., Saito, K., Ando, N., Takizawa, T., Kageyama, Y. and Kihara, K. (2006). Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract. BJU Int. 97, 1322-1326.
32. Parker, D. C., Folpe, A. L., Bell, J., Oliva, E., Young, R. H., Cohen, C. and Amin, M. B. (2003). Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am. J. Surg. Pathol. 27, 1-10.
33. Pirkmajer, S. and Chibalin, A. V. (2011). Serum starvation: caveat emptor. Am. J. Physiol. Cell Physiol. 301, C272-C279.
34. Ruck, A. and Paulie, S. (1997). The epidermal growth factor receptor is involved in autocrine growth of human bladder carcinoma cell lines. Anticancer Res. 17, 1925-1931.
35. Ruck, A. and Paulie, S. (1998). EGF, TGF alpha, AR and HB-EGF are autocrine growth factors for human bladder carcinoma cell lines. Anticancer Res. 18, 1447-1452.
36. Ruck, A., Jakobson, E., Björkman, S. and Paulie, S. (1994). Adaptation of human bladder carcinoma cell lines to serum-free growth. Evidence for autocrine growth stimulation. Anticancer Res. 14, 55-60.
37. Sakakibara, K., Sato, K., Yoshino, K., Oshiro, N., Hirahara, S., Mahbub Hasan, A. K. M., Iwasaki, T., Ueda, Y., Iwao, Y., Yonezawa, K. et al. (2005). Molecular identification and characterization of Xenopus egg uroplakin III, an egg raftassociated transmembrane protein that is tyrosine-phosphorylated upon fertilization. J. Biol. Chem. 280, 15029-15037.
38. Sanderson, M. P., Dempsey, P. J. and Dunbar, A. J. (2006). Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors. Growth Factors 24, 121-136.
39. Sato, K., Sato, A., Aoto, M. and Fukami, Y. (1995). c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem. Biophys. Res. Commun. 215, 1078-1087.
40. Schönfelder, E. M., Knüppel, T., Tasic, V., Miljkovic, P., Konrad, M., Wühl, E., Antignac, C., Bakkaloglu, A., Schaefer, F., Weber, S. et al. (2006). Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia in humans. Am. J. Kidney Dis. 47, 1004-1012.
41. Simons, K. and Toomre, D. (2000). Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1, 31-39.
42. Tavaluc, R. T., Hart, L. S., Dicker, D. T. and El-Deiry, W. S. (2007). Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines. Cell Cycle 6, 2554-2562.
43. Thomas, S. M. and Brugge, J. S. (1997). Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13, 513-609.
44. Thumbikat, P., Berry, R. E., Schaeffer, A. J. and Klumpp, D. J. (2009a). Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli. Microbes Infect. 11, 57-65.
45. Thumbikat, P., Berry, R. E., Zhou, G., Billips, B. K., Yaggie, R. E., Zaichuk, T., Sun, T. T., Schaeffer, A. J. and Klumpp, D. J. (2009b). Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog. 5, e1000415.
46. Wu, X. R. and Sun, T. T. (1993). Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. J. Cell Sci. 106, 31-43.
47. Wu, X. R., Manabe, M., Yu, J. and Sun, T. T. (1990). Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation. J. Biol. Chem. 265, 19170-19179.
48. Wu, X. R., Lin, J. H., Walz, T., Häner, M., Yu, J., Aebi, U. and Sun, T. T. (1994). Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J. Biol. Chem. 269, 13716-13724.
49. Wu, X. R., Kong, X. P., Pellicer, A., Kreibich, G. and Sun, T. T. (2009). Uroplakins in urothelial biology, function, and disease. Kidney Int. 75, 1153-1165.
50. Yamamoto, N., Mammadova, G., Song, R. X., Fukami, Y. and Sato, K. (2006). Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells. J. Cell Sci. 119, 4623-4633.
51. Yang, J., Takahashi, Y., Cheng, E., Liu, J., Terranova, P. F., Zhao, B., Thrasher, J. B., Wang, H. G. and Li, B. (2010). GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death. J. Cell Sci. 123, 861-870.